Improving mRNA vaccines to better fight COVID-19 variants
Official title: Optimizing mRNA sequences with deep neural networks
Funded at University of Texas Hlth Sci Ctr Houston · NIH-10796505 · Data updated 2026-11-12
This study is looking at ways to make COVID-19 mRNA vaccines even better at protecting you from new virus variants by using advanced technology to improve the vaccine's design.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | August 26, 2024 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $351,000 |
| NIH project number | 1R01LM014156-01A1 |
| Project ID | NIH-10796505 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who are at risk of COVID-19 infection, particularly those who have received previous vaccinations but may be vulnerable to variants.
✕Less likely to help
Patients who have not been vaccinated against COVID-19 or those who are not at risk of severe illness from the virus may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the effectiveness of mRNA vaccines against emerging variants of the COVID-19 virus. By utilizing deep neural networks, the team aims to optimize mRNA sequences to improve the immune response generated by these vaccines. The study will analyze the genetic mutations of the virus and how they affect vaccine efficacy, ultimately seeking to develop more robust vaccination strategies. Patients may benefit from improved vaccine formulations that provide better protection against variants.
Why it matters
Potential benefit: If successful, this research could lead to more effective mRNA vaccines that better protect against COVID-19 variants.
How similar studies have gone: Other research has shown promise in optimizing vaccine responses through genetic modifications, indicating that this approach could yield significant advancements.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Zhou, Xiaobo — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Zhou, Xiaobo
Related research
Other NIH-funded projects on the same topics.
-
Administrative and Engagement Core to support Cancer Control efforts
This grant funds a team that helps coordinate, communicate, and engage with communities to advance cancer control efforts.
-
Administrative and Engagement Core for Cancer Control
A core team will coordinate administration, communications, and community engagement to support cancer control efforts across several Texas institutions.
-
Understanding how neural crest cells shape the bones of the skull
A researcher will study how signals control the skull’s sutures, with potential to improve diagnosis and treatment of conditions like craniosynostosis.
-
Alzheimer’s disease and related brain changes linked to chemicals in the body
This NIH grant supports a patient-centered effort to map how environmental exposures and body chemistry relate to Alzheimer’s disease and related dementias.
-
Understanding how everyday exposures affect Alzheimer's disease progression
A national research effort is studying how environmental exposures, gut health, diet, and metabolism relate to Alzheimer's and related dementias to identify new ways to diagnose and treat these conditions.
-
How environment, gut health, and metabolism affect Alzheimer’s disease
This grant looks at how environmental exposures, gut microbes, diet, and metabolism influence Alzheimer’s disease and related dementias.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.